Replies to post #9830 on Aurinia Pharmaceuticals Inc (AUPH)

[atalia]

Very nice write up,thank you.

[Pepperchino]

Thanks CG, your analysis is very much appreciated!

[lidopete]

Buy out rumors is what will push the stock price, company can sell now with CVR for next indications

[Lunacy_John Galt]

Nice thoughts on this Cool. I'm with you...

Ended up being 40% of the trial was black/hispanic, 15% % 25% respectively. Seemingly having no impact on results. Additional data at future conferences will shed more light, but it's a non-issue at this point imo.

Assuming they don't drop an offering AH tomorrow, this can definitely run for a few days just like last time.

Haven't sold a share. Holding out for much more than $15.

[lidopete]

Cool, is there any truth to the below on Twitter that the patent could allow generics at 2028-29
Thanks i advance- Lido


jerome leonard
@jeromeleonard5
·
55m
Replying to
@ATLanalyst
"Likely 6m pediatric extension into 2028. Manufacturing exclusivity with lonza until ‘31. If ‘37 gets invalidated it’s generic in 28-29. Pretty short exclusivity.. moa patents not most reliable. Although there are precedents.. if 37 was a certainty we would already trade at 30"